3//SEC Filing
ALGORX PHARMACEUTICALS INC 3
Accession 0001209191-05-008190
CIK 0001139029other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 2:31 PM ET
Size
7.2 KB
Accession
0001209191-05-008190
Insider Transaction Report
Form 3
COHEN CHARLES
Director
Holdings
- (indirect: see footnote)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (20,349 underlying)
Footnotes (2)
- [F1]Each share of Series C Preferred Stock shall be automatically converted into Common Stock upon the closing of the Issuer's initial public offering and has no expiration date.
- [F2]Shares are indirectly beneficially owned as a limited partner of Advent Partners HLS III Limited Partnership.
Issuer
ALGORX PHARMACEUTICALS INC
CIK 0001139029
Entity typeother
Related Parties
1- filerCIK 0001139029
Filing Metadata
- Form type
- 3
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 2:31 PM ET
- Size
- 7.2 KB